<!DOCTYPE html>
    <html lang="en">
        <head>
            <title data-react-helmet="true">Antibody drugs are no cure but seem promising for COVID-19 | CBC News</title>
            <meta charset="utf-8" />
            <meta name="viewport" content="width=device-width, initial-scale=1" />
            <link rel="manifest" href="/a/manifest.json" />
            <link rel="apple-touch-icon" href="/a/apple-touch-icon.png" />
            <link rel="icon" type="image/x-icon" href="/a/favicon.ico" />
            <!-- Resource Hints -->
            <link
                rel="preload"
                href="/a/styles/fonts-css/fonts/Open-Sans-Regular.woff"
                as="font"
                type="font/woff"
                crossorigin
            />
            <link
                rel="preload"
                href="/a/styles/fonts-css/fonts/Open-Sans-Bold.woff"
                as="font"
                type="font/woff"
                crossorigin
            />
            <link
                rel="preload"
                href="/a/styles/fonts-css/fonts/Stag-Medium-Web.woff"
                as="font"
                type="font/woff"
                crossorigin
            />
            <link
                rel="preload"
                href="/i/caffeine/css/caffeine.css"
                as="style"
                crossorigin
            />
            <link rel="preconnect" href="https://i.cbc.ca" crossorigin />
            <link rel="dns-prefetch" href="https://i.cbc.ca" crossorigin />
            <link rel="preconnect" href="https://uie.data.cbc.ca" crossorigin />
            <link rel="dns-prefetch" href="https://uie.data.cbc.ca" crossorigin />
            <link
                rel="preconnect"
                href="https://subscriptions.cbc.ca"
                crossorigin
            />
            <link
                rel="dns-prefetch"
                href="https://subscriptions.cbc.ca"
                crossorigin
            />
            <link rel="preconnect" href="https://mb.moatads.com" crossorigin />
            <link rel="dns-prefetch" href="https://mb.moatads.com" crossorigin />
            <link rel="preconnect" href="https://geo.moatads.com" crossorigin />
            <link rel="dns-prefetch" href="https://geo.moatads.com" crossorigin />
            <link
                rel="preconnect"
                href="https://cdn-cbc-v3.conductrics.com"
                crossorigin
            />
            <link
                rel="dns-prefetch"
                href="https://cdn-cbc-v3.conductrics.com"
                crossorigin
            />
            <link
                rel="preconnect"
                href="https://static.chartbeat.com"
                crossorigin
            />
            <link
                rel="dns-prefetch"
                href="https://static.chartbeat.com"
                crossorigin
            />
            <link rel="preconnect" href="https://ad.crwdcntrl.net" crossorigin />
            <link rel="dns-prefetch" href="https://ad.crwdcntrl.net" crossorigin />
            <link rel="preconnect" href="https://tags.crwdcntrl.net" crossorigin />
            <link
                rel="dns-prefetch"
                href="https://tags.crwdcntrl.net"
                crossorigin
            />
            <link
                rel="preconnect"
                href="https://www.googletagservices.com"
                crossorigin
            />
            <link
                rel="dns-prefetch"
                href="https://www.googletagservices.com"
                crossorigin
            />
            <link rel="preconnect" href="https://adservice.google.ca" crossorigin />
            <link
                rel="dns-prefetch"
                href="https://adservice.google.ca"
                crossorigin
            />
            <link
                rel="preconnect"
                href="https://pagead2.googlesyndication.com"
                crossorigin
            />
            <link
                rel="dns-prefetch"
                href="https://pagead2.googlesyndication.com"
                crossorigin
            />
            <link
                rel="preconnect"
                href="https://securepubads.g.doubleclick.net"
                crossorigin
            />
            <link
                rel="dns-prefetch"
                href="https://securepubads.g.doubleclick.net"
                crossorigin
            />
            <!-- Admiral Tag -->
            <script type="text/javascript">
                !(function(o, n, t) {
                    (t = o.createElement(n)),
                        (o = o.getElementsByTagName(n)[0]),
                        (t.async = 1),
                        (t.src =
                            "https://sombersurprise.com/v2/0/pjeU_IMsGJZO75yCdWtjjhHHUWg80SC3aYT60eWAbE4cH1eQidKmz7zT_EZex-0yDV52nwW_DHqug"),
                        o.parentNode.insertBefore(t, o);
                })(document, "script"),
                    (function(o, n) {
                        o[n] =
                            o[n] ||
                            function() {
                                (o[n].q = o[n].q || []).push(arguments);
                            };
                    })(window, "admiral");
                !(function(n, e, r, t) {
                    function o() {
                        if (
                            (function o(t) {
                                try {
                                    return (
                                        (t = localStorage.getItem("v4ac1eiZr0")) &&
                                        0 < t.split(",")[4]
                                    );
                                } catch (n) {}
                                return !1;
                            })()
                        ) {
                            var t = n[e].pubads();
                            typeof t.setTargeting === r &&
                                t.setTargeting("admiral-engaged", "true");
                        }
                    }
                    ((t = n[e] = n[e] || {}).cmd = t.cmd || []),
                        typeof t.pubads === r
                            ? o()
                            : typeof t.cmd.unshift === r
                            ? t.cmd.unshift(o)
                            : t.cmd.push(o);
                })(window, "googletag", "function");
            </script>
            <script type="text/javascript" src="//js-sec.indexww.com/ht/p/182851-247776411096411.js"></script>
            <script
                type="text/javascript"
                src="https://z.moatads.com/cbcprebidheader885986590025/moatheader.js"
            ></script>
            <link data-react-helmet="true" rel="canonical" href="https://www.cbc.ca/news/health/covid-19-antibody-treatments-1.5755755"/>
            <link rel="amphtml" href="https://www.cbc.ca/amp/1.5755755" />
            <meta data-react-helmet="true" property="og:site_name" content="CBC"/><meta data-react-helmet="true" property="fb:pages" content="5823419603"/><meta data-react-helmet="true" property="og:url" content="https://www.cbc.ca/news/health/covid-19-antibody-treatments-1.5755755"/><meta data-react-helmet="true" property="og:title" content="Antibody drugs are no cure but seem promising for COVID-19 | CBC News"/><meta data-react-helmet="true" property="og:image" content="https://i.cbc.ca/1.5755765.1602185123!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_620/virus-outbreak-antibody-drugs.jpg"/><meta data-react-helmet="true" property="og:description" content="Experimental antibody drugs being tested for treating and preventing coronavirus infections."/><meta data-react-helmet="true" property="vf:section" content="2.632"/><meta data-react-helmet="true" property="og:locale" content="en_US"/><meta data-react-helmet="true" property="og:type" content="article"/><meta data-react-helmet="true" property="vf:unique_id" content="1.5755755"/><meta data-react-helmet="true" name="google-site-verification" content="pJy_QmRvDz2tr7X8eQ6Y1L3Se-8RWM_PpJX42Pr_fYo"/><meta data-react-helmet="true" name="twitter:site" content="@cbc"/><meta data-react-helmet="true" name="twitter:title" content="Antibody drugs are no cure but seem promising for COVID-19 | CBC News"/><meta data-react-helmet="true" name="twitter:image" content="https://i.cbc.ca/1.5755765.1602185123!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_620/virus-outbreak-antibody-drugs.jpg"/><meta data-react-helmet="true" name="twitter:player:width" content="640"/><meta data-react-helmet="true" name="twitter:description" content="Experimental antibody drugs being tested for treating and preventing coronavirus infections."/><meta data-react-helmet="true" name="twitter:card" content="summary_large_image"/><meta data-react-helmet="true" name="twitter:player:height" content="360"/><meta data-react-helmet="true" name="description" content="Experimental antibody drugs being tested for treating and preventing coronavirus infections."/>
            <script data-react-helmet="true" type="application/ld+json">{"image":[{"datePublished":"2020-10-08T19:28Z","@type":"ImageObject","name":"Virus Outbreak Antibody Drugs","description":"In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. ","dateModified":"2020-10-08T19:25Z","@context":"http://schema.org/","url":"https://i.cbc.ca/1.5755765.1602185123!/fileImage/httpImage/virus-outbreak-antibody-drugs.jpg"}],"@type":"ReportageNewsArticle","description":"Experimental antibody drugs being tested for treating and preventing coronavirus infections.","alternateName":"Experimental treatments aim to help the immune system clear the virus","dateModified":"2020-10-08T20:27Z","video":[{"datePublished":"2020-10-06T01:28Z","alternativeHeadline":"U.S. President Donald Trump has received 3 different treatments for COVID-19, which are separately designed to treat patients with mild, moderate and severe symptoms.","identifier":"1800847427994","@type":"VideoObject","name":"Trump given COVID-19 treatments for varying degrees of illness","description":"U.S. President Donald Trump has received 3 different treatments for COVID-19, which are separately designed to treat patients with mild, moderate and severe symptoms.","dateModified":"2020-10-06T02:02Z","@context":"http://schema.org/","thumbnailUrl":"https://thumbnails.cbc.ca/maven_legacy/thumbnails/174/963/covid19-trump-treatment-birak-051020.jpg"}],"@context":"http://schema.org/","datePublished":"2020-10-08T20:27Z","name":"Antibody drugs are no cure but seem promising for COVID-19 ","publisher":{"foundingDate":"1936-11-02T05:00Z","ethicsPolicy":"https://www.cbc.ca/news/about-cbc-news-1.1294364","verificationFactCheckingPolicy":"https://www.cbc.ca/news/about-cbc-news-1.1294364","@type":"NewsMediaOrganization","@context":"http://schema.org/","ownershipFundingInfo":"https://www.cbc.ca/news/about-cbc-news-1.1294364","actionableFeedbackPolicy":"https://www.cbc.ca/news/about-cbc-news-1.1294364","missionCoveragePrioritiesPolicy":"https://www.cbc.ca/news/about-cbc-news-1.1294364","diversityPolicy":"https://www.cbc.ca/news/about-cbc-news-1.1294364","masthead":"https://www.cbc.ca/news/about-cbc-news-1.1294364","diversityStaffingReport":"https://www.cbc.ca/news/about-cbc-news-1.1294364","unnamedSourcesPolicy":"https://www.cbc.ca/news/about-cbc-news-1.1294364","correctionsPolicy":"https://www.cbc.ca/news/about-cbc-news-1.1294364"},"headline":"Antibody drugs are no cure but seem promising for COVID-19","articleSection":"Health","thumbnailUrl":"https://i.cbc.ca/1.5755765.1602185123!/fileImage/httpImage/virus-outbreak-antibody-drugs.jpg"}</script>
            <link data-chunk="Detail" rel="preload" as="style" href="/a/styles/Detail.4bf5cc8d91a97d49cff3.css">
<link data-chunk="app" rel="preload" as="style" href="/a/styles/app.fbb9b4e049b5e3689604.css">
<link data-chunk="app" rel="preload" as="style" href="/a/styles/vendor.272a148a3fd4ab8b2203.css">
<link data-chunk="app" rel="preload" as="script" href="/a/scripts/runtime.85a465446ba6cd41e3f9.js">
<link data-chunk="app" rel="preload" as="script" href="/a/scripts/react.fe75a712eb78fd26b2cb.js">
<link data-chunk="app" rel="preload" as="script" href="/a/scripts/vendor.be7d21571f35ecbfe132.js">
<link data-chunk="app" rel="preload" as="script" href="/a/scripts/app.638f1338f55e344a00bd.js">
<link data-chunk="Detail" rel="preload" as="script" href="/a/scripts/vendors~Detail~Detail.NoDate~DetailNoAds~Index~Landing~Landing.NoDate~Landing.NoLoadMore~LandingFeat~970bb718.13aed3c6f60a4a95b273.js">
<link data-chunk="Detail" rel="preload" as="script" href="/a/scripts/vendors~Detail~Detail.NoDate~DetailNoAds~Preview.916679f692a7f8532fed.js">
<link data-chunk="Detail" rel="preload" as="script" href="/a/scripts/ErrorPage.38bd081a56974bdfaa7a.js">
<link data-chunk="Detail" rel="preload" as="script" href="/a/scripts/BlankPage~Detail~Detail.NoDate~DetailNoAds~FinancePage~Index~Landing~Landing.NoDate~Landing.NoLoadMo~524c369c.752336a0b79086df605d.js">
<link data-chunk="Detail" rel="preload" as="script" href="/a/scripts/Detail.32dda8c9fbfebbee57a9.js">
            <link data-chunk="app" rel="stylesheet" href="/a/styles/vendor.272a148a3fd4ab8b2203.css">
<link data-chunk="app" rel="stylesheet" href="/a/styles/app.fbb9b4e049b5e3689604.css">
<link data-chunk="Detail" rel="stylesheet" href="/a/styles/Detail.4bf5cc8d91a97d49cff3.css">
            <script>
                (function(){
                  // Only apply the following script to the www.cbc.ca domain
                  // Not inserting this at Edge anymore for Brotli support
                  if (window.location.host !== "www.cbc.ca") {
                    return;
                  }

                  // Boomerang Loader Snippet version 10
                  if (window.BOOMR && (window.BOOMR.version || window.BOOMR.snippetExecuted)) {
                    return;
                  }

                  window.BOOMR = window.BOOMR || {};
                  window.BOOMR.snippetExecuted = true;

                  var dom, doc, where, iframe = document.createElement("iframe"), win = window;

                  function boomerangSaveLoadTime(e) {
                    win.BOOMR_onload = (e && e.timeStamp) || new Date().getTime();
                  }

                  if (win.addEventListener) {
                    win.addEventListener("load", boomerangSaveLoadTime, false);
                  } else if (win.attachEvent) {
                    win.attachEvent("onload", boomerangSaveLoadTime);
                  }

                  iframe.src = "javascript:void(0)";
                  iframe.title = "";
                  iframe.role = "presentation";
                  (iframe.frameElement || iframe).style.cssText = "width:0;height:0;border:0;display:none;";
                  where = document.getElementsByTagName("script")[0];
                  where.parentNode.insertBefore(iframe, where);

                  try {
                    doc = iframe.contentWindow.document;
                  } catch (e) {
                    dom = document.domain;
                    iframe.src = "javascript:var d=document.open();d.domain='" + dom + "';void(0);";
                    doc = iframe.contentWindow.document;
                  }

                  doc.open()._l = function() {
                    var js = this.createElement("script");
                    if (dom) {
                      this.domain = dom;
                    }
                    js.id = "boomr-if-as";
                    js.src = "https://s.go-mpulse.net/boomerang/" +
                    "PV5QJ-UM4B9-ECQUJ-YKUFG-EAKA2";
                    BOOMR_lstart = new Date().getTime();
                    this.body.appendChild(js);
                  };
                  doc.write('<bo' + 'dy onload="document._l();">');
                  doc.close();
                })();
            </script>
        </head>

        <body class="feed">
            <script id="initialStateDom">window.__INITIAL_STATE__ = {"trending":{"sections":{},"list":[]},"content":{"list":[],"section":"","status":"","contentType":""},"topic":{"topicList":[],"topicSection":""},"sectionalContent":{},"density":{"selection":""},"loader":{"loaded":true,"count":0},"detail":{"content":{"id":"1.5755755","type":"story","source":"","corrections":[],"clarifications":[],"headline":"Antibody drugs are no cure but seem promising for COVID-19","shareheadline":"Antibody drugs are no cure but seem promising for COVID-19","originalheadline":"Antibody drugs are no cure but seem promising for COVID-19","deck":"Experimental treatments aim to help the immune system clear the virus","summary":"Experimental antibody drugs being tested for treating and preventing coronavirus infections.","byline":"The Associated Press","highlights":{"highlight":[],"label":"Updated"},"intlinks":[],"extlinks":[],"updatedAt":1602188879511,"publishedAt":1602188879511,"publishedAtVerbal":"Oct 08, 2020 4:27 PM ET","displayComments":false,"url":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fhealth\u002Fcovid-19-antibody-treatments-1.5755755","category":"","flag":"","body":"\u003Cp\u003EThey're not cures and it's not likely that everyone will be able to get them as U.S. President Donald Trump has suggested. But experimental antibody drugs like the one Trump was given are among the most promising therapies being tested for treating and preventing coronavirus infections.\u003C\u002Fp\u003E  \u003Cp\u003EEli Lilly and Regeneron Pharmaceuticals Inc. are asking the U.S. government to allow emergency use of their antibody drugs, which aim to help the immune system clear the virus. The medicines are still in testing; their safety and effectiveness are not yet known.\u003C\u002Fp\u003E  \u003Cp\u003E\u003Cem\u003E\u003Cstrong\u003EWATCH | Trump's COVID-19 treatments:\u003C\u002Fstrong\u003E\u003C\u002Fem\u003E\u003C\u002Fp\u003E  \u003Cp\u003E[MEDIA]\u003C\u002Fp\u003E  \u003Cp\u003ETrump is among fewer than 10 people who were able to access the Regeneron one under \"compassionate use\" rules, without enrolling in a study.\u003C\u002Fp\u003E  \u003Ch2\u003EQ: How do they work?\u003C\u002Fh2\u003E  \u003Cp\u003EA: Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production. But it can take several weeks after a vaccine or natural infection for the most effective antibodies to form. The experimental drugs are concentrated versions of specific antibodies that worked best against the coronavirus in lab and animal tests. In theory, they start helping right away. The one-time treatment is given through an IV — it's not like a pill that people can take at home.\u003C\u002Fp\u003E  \u003Ch2\u003EQ: How do the drugs differ?\u003C\u002Fh2\u003E  \u003Cp\u003EA: Regeneron is using two antibodies to enhance chances its therapy will work even if the virus evades one. The company made a successful Ebola combo antibody treatment this way. Lilly is testing two different antibodies — one with the Canadian company \u003Ca href=\"http:\u002F\u002Fcbc.ca\u002F1.5507232\"\u003EAbCellera\u003C\u002Fa\u003E and another with a Chinese company, Junshi Biosciences — individually and in combination.\u003C\u002Fp\u003E  \u003Cp\u003EOthers testing similar drugs are GlaxoSmithKline and Vir Biotechnology Inc., which says it has engineered antibodies to last longer than they usually do. Amgen, Adaptive Biotechnologies and the Singapore biotech company Tychan Pte Ltd. also have studies underway.\u003C\u002Fp\u003E  \u003Ch2\u003EQ: When might they be available?\u003C\u002Fh2\u003E  \u003Cp\u003EA: Eli Lilly and Regeneron have asked the U.S. Food and Drug Administration for emergency authorization. During public health emergencies the FDA can speed drugs to market based on a lower standard of evidence than is normally required.\u003C\u002Fp\u003E  \u003Cp\u003EDrugmakers need only show that the expected benefits of their therapies outweigh the risks for treating COVID-19. There is no deadline for the FDA to rule on the drugs, but it typically makes decisions on such emergency applications within days or weeks.\u003C\u002Fp\u003E  \u003Ch2\u003EQ: Who would get them?\u003C\u002Fh2\u003E  \u003Cp\u003EA: Researchers are still trying to determine the best candidates for antibody treatment. Some studies involve newly infected people to see if early treatment can lower the risk of becoming sick. Other studies in hospitalized patients aim to prevent serious illness, complications or death. Researchers also are testing these drugs to try to prevent infection in people at high risk of it, such as health workers, housemates of people with COVID-19, and nursing home workers and residents.\u003C\u002Fp\u003E  \u003Ch2\u003EQ: Will there be enough for everyone?\u003C\u002Fh2\u003E  \u003Cp\u003EA: It depends on how potent the drugs prove to be, something still being studied. If a high dose is needed to be effective, it will mean that fewer people can be treated with limited supplies. Regeneron says it has enough doses for approximately 50,000 patients and expects 300,000 available within the next few months.\u003C\u002Fp\u003E  \u003Cp\u003EUnder a $450 million US contract, the U.S. government has agreed to buy initial supplies of Regeneron's drug and distribute them at no cost to U.S. patients. Lilly says it expects to have 1 million doses this year of the single antibody that it submitted to FDA. However, the company's research has focused on a combination of two antibodies to treat COVID-19 patients. Lilly said it expects to have just 50,000 doses of that combo this year.\u003C\u002Fp\u003E  \u003Ch2\u003EQ: What's the evidence that they work?\u003C\u002Fh2\u003E  \u003Cp\u003EA: Lilly and Regeneron have revealed only partial results in news releases; they haven't been published or vetted by independent scientists. Lilly said Wednesday that its two-antibody combo reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19. The results are an interim look at a mid-stage study in which 112 people received the antibodies and 156 got a placebo.\u003C\u002Fp\u003E  \u003Cp\u003EThe amount of virus was significantly lower 11 days later in those given the drug — the main goal of the study. About 5.8 per cent&nbsp;of patients given placebo required hospitalization or an emergency room visit versus 0.9 per cent&nbsp;of those given the antibodies. Previously, Regeneron said its drug reduced the amount of virus and symptoms in non-hospitalized patients. The partial results came from the first 275 patients enrolled in ongoing studies.\u003C\u002Fp\u003E","keywords":[{"entities":[{"name":"Health\u002FDiagnosis and treatment\u002FMedication","id":"subject-E237BE707DE410048FFFDF092526B43E","uri":null},{"name":"Health\u002FDiseases and conditions\u002FInfectious diseases\u002FCoronavirus","id":"subject-bdf41fec-8adb-40d5-b1b9-4adaed34891d","uri":null},{"name":"Science\u002FBiology\u002FVirology","id":"subject-0C341B1085D81004842EFF2260DD383E","uri":null},{"name":"Technology\u002FBiotechnology","id":"subject-707877188B6B10048BFEA385CD5CE603","uri":null},{"name":"Health\u002FPublic health\u002FImmunizations","id":"subject-ACE74E307F00100486CEDF092526B43E","uri":null}],"name":"Subject","id":"department.categorydimension.subject"},{"entities":[{"name":"Donald Trump","id":"Donald Trump"},{"name":"Eli Lilly","id":"Eli Lilly"}],"name":"Person","id":"department.categorydimension.tag.Person"},{"entities":[{"name":"Eli Lilly and Company","id":"Eli Lilly and Company"},{"name":"Medicines","id":"Medicines"}],"name":"Company","id":"department.categorydimension.tag.Company"},{"entities":[{"name":"U.S. Food and Drug Administration","id":"U.S. Food and Drug Administration"}],"name":"Organization","id":"department.categorydimension.tag.Organisation"},{"entities":[{"name":"COVID-19","id":"COVID-19"},{"name":"coronavirus","id":"coronavirus"}],"name":"Tag","id":"department.categorydimension.tag.Tag"},{"entities":[],"name":"Location","id":"department.categorydimension.tag.Location"},{"entities":[],"name":"Collections","id":"department.categorydimension.tag.Collections"}],"segments":[],"episode":{},"vfsection":"2.632","headlineImageURL":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_620\u002Fvirus-outbreak-antibody-drugs.jpg","departments":[{"name":"news","label":"News","id":"2.630","referencename":""},{"name":"health","label":"Health","id":"2.632","referencename":""}],"attribution":{"level1":"news","level3":"","level2":"health"},"authorProfile":{"bio":{"name":null,"photo":{},"id":null,"biography":null,"title":null},"authorbio":"none","authors":[]},"isPreview":false,"adExclusions":[],"sponsorBio":{},"workflowanalysis":{"tags":""},"authorStories":[],"subject":[{"name":"Health\u002FDiagnosis and treatment\u002FMedication","id":"subject-E237BE707DE410048FFFDF092526B43E","uri":null},{"name":"Health\u002FDiseases and conditions\u002FInfectious diseases\u002FCoronavirus","id":"subject-bdf41fec-8adb-40d5-b1b9-4adaed34891d","uri":null},{"name":"Science\u002FBiology\u002FVirology","id":"subject-0C341B1085D81004842EFF2260DD383E","uri":null},{"name":"Technology\u002FBiotechnology","id":"subject-707877188B6B10048BFEA385CD5CE603","uri":null},{"name":"Health\u002FPublic health\u002FImmunizations","id":"subject-ACE74E307F00100486CEDF092526B43E","uri":null}],"authorList":[],"newsletters":"false","embedtypes":["video","photo"],"contentarea":"news","subsection1":"health","subsection2":"","subsection3":"","subsection4":"","wordcount":773,"leadmedia":{"jsonurl":"\u002Fjson\u002Fcmlink\u002Fvirus-outbreak-antibody-drugs-1.5755765","deck":"In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. ","description":"In this undated image from video provided by Regeneron Pharmaceuticals on Oct. 2, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. ","title":"Virus Outbreak Antibody Drugs","type":"image","url":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fhealth\u002Fvirus-outbreak-antibody-drugs-1.5755765","showcaption":true,"originalimage":{"w":2301,"h":1534,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fvirus-outbreak-antibody-drugs.jpg"},"derivatives":{"16x9_940":{"w":940,"h":529,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_940\u002Fvirus-outbreak-antibody-drugs.jpg"},"16x9_300":{"w":300,"h":168,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_300\u002Fvirus-outbreak-antibody-drugs.jpg"},"16x9_620":{"w":620,"h":349,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_620\u002Fvirus-outbreak-antibody-drugs.jpg"},"original_620":{"w":620,"h":413,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002Foriginal_620\u002Fvirus-outbreak-antibody-drugs.jpg"},"original_300":{"w":300,"h":200,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002Foriginal_300\u002Fvirus-outbreak-antibody-drugs.jpg"},"16x9tight_140":{"w":140,"h":79,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9tight_140\u002Fvirus-outbreak-antibody-drugs.jpg"},"16x9_460":{"w":460,"h":259,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_460\u002Fvirus-outbreak-antibody-drugs.jpg"}},"size":"full","useoriginalimage":false,"originalimageurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fvirus-outbreak-antibody-drugs.jpg","id":"1.5755765","credit":"Regeneron\u002FAssociated Press","headline":"Virus Outbreak Antibody Drugs"},"photogalleries":[],"storyimages":[{"jsonurl":"\u002Fjson\u002Fcmlink\u002Fvirus-outbreak-antibody-drugs-1.5755765","deck":"In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. ","description":"In this undated image from video provided by Regeneron Pharmaceuticals on Oct. 2, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. ","title":"Virus Outbreak Antibody Drugs","type":"image","url":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fhealth\u002Fvirus-outbreak-antibody-drugs-1.5755765","showcaption":true,"originalimage":{"w":2301,"h":1534,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fvirus-outbreak-antibody-drugs.jpg"},"derivatives":{"16x9_940":{"w":940,"h":529,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_940\u002Fvirus-outbreak-antibody-drugs.jpg"},"16x9_300":{"w":300,"h":168,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_300\u002Fvirus-outbreak-antibody-drugs.jpg"},"16x9_620":{"w":620,"h":349,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_620\u002Fvirus-outbreak-antibody-drugs.jpg"},"original_620":{"w":620,"h":413,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002Foriginal_620\u002Fvirus-outbreak-antibody-drugs.jpg"},"original_300":{"w":300,"h":200,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002Foriginal_300\u002Fvirus-outbreak-antibody-drugs.jpg"},"16x9tight_140":{"w":140,"h":79,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9tight_140\u002Fvirus-outbreak-antibody-drugs.jpg"},"16x9_460":{"w":460,"h":259,"fileurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_460\u002Fvirus-outbreak-antibody-drugs.jpg"}},"size":"full","useoriginalimage":false,"originalimageurl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fvirus-outbreak-antibody-drugs.jpg","id":"1.5755765","credit":"Regeneron\u002FAssociated Press","headline":"Virus Outbreak Antibody Drugs"}],"customcontent":[{"html":"","type":"coveritlive"}],"embeddedcontent":[],"similarlinks":[],"gs_categories":[],"gs_keywords":[],"media":[{"showcaption":true,"clipID":"1800847427994","title":"Trump given COVID-19 treatments for varying degrees of illness","source":"MPX","description":"U.S. President Donald Trump has received 3 different treatments for COVID-19, which are separately designed to treat patients with mild, moderate and severe symptoms.","thumbnail":"https:\u002F\u002Fthumbnails.cbc.ca\u002Fmaven_legacy\u002Fthumbnails\u002F174\u002F963\u002Fcovid19-trump-treatment-birak-051020.jpg","airDate":1601947680000,"runtime":120.454,"captions":{"src":"https:\u002F\u002Fcbccaption.cbc.ca\u002F174\u002F963\u002Fcovid19-trump-treatment-birak-051020_cc.vtt"},"categories":["News","News\u002FWorld","News\u002FTV Shows\u002FThe National","News\u002FHealth","News\u002FTV Shows\u002FThe National\u002FWorld"],"mediatype":"video","liveondemand":"On-Demand"}]},"media":{"runtime":0,"clipID":"","description":"","isLead":true,"autoPlay":false,"title":""},"image":{"title":"","deck":"In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. ","credit":"Regeneron\u002FAssociated Press","url":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_780\u002Fvirus-outbreak-antibody-drugs.jpg","showcaption":true,"description":"In this undated image from video provided by Regeneron Pharmaceuticals on Oct. 2, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. ","mass":"full","type":"leadmedia-story"},"gallery":{"id":"","leadmedia":true},"author":{"img":"","names":[],"title":"","authorInfo":""},"audio":{"runtime":0,"clipID":"","url":"","mediaID":"","description":"","isLead":true,"autoPlay":false}},"app":{"path":"news\u002Fhealth\u002Fcovid-19-antibody-treatments-1.5755755","baseSection":"news","baseNavSection":"news","subSection":"health","section":"news\u002Fhealth","sponsored":false,"pageType":"detail","ad_hierarchy":"\u002F5876\u002Fnews\u002Fhealth\u002Fstory","contentId":"1.5755755","contentType":"story","title":"Antibody drugs are no cure but seem promising for COVID-19 | CBC News","meta":{"canonical":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fhealth\u002Fcovid-19-antibody-treatments-1.5755755","jsonld":{"image":[{"datePublished":"2020-10-08T19:28Z","@type":"ImageObject","name":"Virus Outbreak Antibody Drugs","description":"In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. ","dateModified":"2020-10-08T19:25Z","@context":"http:\u002F\u002Fschema.org\u002F","url":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fvirus-outbreak-antibody-drugs.jpg"}],"@type":"ReportageNewsArticle","description":"Experimental antibody drugs being tested for treating and preventing coronavirus infections.","alternateName":"Experimental treatments aim to help the immune system clear the virus","dateModified":"2020-10-08T20:27Z","video":[{"datePublished":"2020-10-06T01:28Z","alternativeHeadline":"U.S. President Donald Trump has received 3 different treatments for COVID-19, which are separately designed to treat patients with mild, moderate and severe symptoms.","identifier":"1800847427994","@type":"VideoObject","name":"Trump given COVID-19 treatments for varying degrees of illness","description":"U.S. President Donald Trump has received 3 different treatments for COVID-19, which are separately designed to treat patients with mild, moderate and severe symptoms.","dateModified":"2020-10-06T02:02Z","@context":"http:\u002F\u002Fschema.org\u002F","thumbnailUrl":"https:\u002F\u002Fthumbnails.cbc.ca\u002Fmaven_legacy\u002Fthumbnails\u002F174\u002F963\u002Fcovid19-trump-treatment-birak-051020.jpg"}],"@context":"http:\u002F\u002Fschema.org\u002F","datePublished":"2020-10-08T20:27Z","name":"Antibody drugs are no cure but seem promising for COVID-19 ","publisher":{"foundingDate":"1936-11-02T05:00Z","ethicsPolicy":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","verificationFactCheckingPolicy":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","@type":"NewsMediaOrganization","@context":"http:\u002F\u002Fschema.org\u002F","ownershipFundingInfo":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","actionableFeedbackPolicy":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","missionCoveragePrioritiesPolicy":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","diversityPolicy":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","masthead":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","diversityStaffingReport":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","unnamedSourcesPolicy":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364","correctionsPolicy":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fabout-cbc-news-1.1294364"},"headline":"Antibody drugs are no cure but seem promising for COVID-19","articleSection":"Health","thumbnailUrl":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fvirus-outbreak-antibody-drugs.jpg"},"description":"Experimental antibody drugs being tested for treating and preventing coronavirus infections.","twitter:card":"summary_large_image","twitter:site":"@cbc","twitter:title":"Antibody drugs are no cure but seem promising for COVID-19 | CBC News","twitter:description":"Experimental antibody drugs being tested for treating and preventing coronavirus infections.","twitter:image":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_620\u002Fvirus-outbreak-antibody-drugs.jpg","twitter:player":"","twitter:player:width":"640","twitter:player:height":"360","google-site-verification":"pJy_QmRvDz2tr7X8eQ6Y1L3Se-8RWM_PpJX42Pr_fYo","robots":"","vf:unique_id":"1.5755755","vf:section":"2.632","og:url":"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fhealth\u002Fcovid-19-antibody-treatments-1.5755755","og:title":"Antibody drugs are no cure but seem promising for COVID-19 | CBC News","og:image":"https:\u002F\u002Fi.cbc.ca\u002F1.5755765.1602185123!\u002FfileImage\u002FhttpImage\u002Fimage.jpg_gen\u002Fderivatives\u002F16x9_620\u002Fvirus-outbreak-antibody-drugs.jpg","og:description":"Experimental antibody drugs being tested for treating and preventing coronavirus infections.","og:type":"article","fb:pages":"5823419603","og:locale":"en_US","og:site_name":"CBC","video:duration":"","video:release_date":""},"defaultHeadlineImage":"","statusCode":200,"themeClassNames":"detail newsTheme storyType healthSection"},"photogallery":{"items":{}},"regions":{"selected":{},"isExplicitlySet":false,"regionList":null},"tracking":{"tracking":{}},"videoContent":{"list":{},"detail":{"contentId":-1,"sourceId":"","title":"","description":"","imageURL":"","publishTime":"","availableDate":"","unavailableDate":"","url":"","source":"mpx","category":"","itemType":"video","approved":false}},"notifications":{"visible":[],"dismissed":[]},"schedule":{},"loadMore":{"disabled":false,"inProgress":false,"isHidden":false},"errors":{"list":[]},"persistentPlayer":{"isVisible":false,"status":"","mediaItem":{},"selector":"persistent-player-inner-container","routeUpdate":false,"placeholderClassName":"","isDocked":false,"disableRecommend":false,"forcePersistence":false},"search":{},"plus":{"content":{},"hasFetchedAudienceFilters":false,"audienceFilters":{},"audienceSegments":[],"adAudiences":[],"audienceSegmentsLoaded":false,"explainerItems":[],"preferences":{}},"cookieJar":{"cookies":null},"nbox":{"items":[],"shortTitleStories":[],"type":null},"fixed":{"date":"2020-10-14T18:28:34.694Z"},"gdpr":{"euCountry":false},"newsletters":{"newsletters":false},"featureflags":{"election.region.news":null,"election.region.news.canada":null,"election.region.news.canada.montreal.quebecvotes2018":"QC2018","election.region.news.canada.new-brunswick":null,"election.region.news.canada.new-brunswick.nbvotes2018":"NB2018","election.region.news.elections.albertavotes2019":"AB2019","election.region.news.elections.nlvotes2019":"NL2019","election.region.news.elections.peivotes2019":"PE2019","election.region.news.politics":null,"globalEventNav":"{\n    \"links\": [\n        {\n            \"link\": \"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fcovid-19\",\n            \"title\": \"COVID-19\"\n        },\n        {\n            \"link\": \"https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Flocal\",\n            \"title\": \"Local updates\"\n        },\n        {\n            \"link\": \"\u002Fplayer\u002Fnews\u002Flive\",\n            \"title\": \"Live video\"\n        },\n        {\n            \"link\": \"https:\u002F\u002Fnewsinteractives.cbc.ca\u002Fcoronavirustracker\u002F\",\n            \"title\": \"COVID-19 tracker\",\n            \"type\": \"external\"\n        },\n        {\n            \"link\": \"https:\u002F\u002Fsubscriptions.cbc.ca\u002Flistmanagement\u002Fforms\u002Fcoronavirusbrief?cmp=feed-gen_coronavirusbrief_newsletter-subscribe\",\n            \"title\": \"Subscribe to newsletter\",\n            \"type\": \"external\"\n        }\n    ]\n}","gqlStoryPages.2017":true,"gqlStoryPages.archives":true,"gqlStoryPages.arts":true,"gqlStoryPages.books":true,"gqlStoryPages.cape":true,"gqlStoryPages.comedy":true,"gqlStoryPages.cree":true,"gqlStoryPages.documentaries":true,"gqlStoryPages.homepage":true,"gqlStoryPages.indspire":true,"gqlStoryPages.learning-english":true,"gqlStoryPages.life":true,"gqlStoryPages.music":true,"gqlStoryPages.news":true,"gqlStoryPages.radio":true,"gqlStoryPages.reflections":true,"gqlStoryPages.sports":true,"gqlStoryPages.television":true,"gqlStoryPages.visualstories":true,"olympics.tokyonav":true,"targetedads.fbpixel":false,"trending.graphqlRollout.distribution":1,"viafoura.header.login":true,"video.landing":true,"widget.music":false,"drp":false,"aggrAPI":"https:\u002F\u002Fwww.cbc.ca\u002F2019\u002Ffailover\u002Fcbc.json","drp_pol":false,"polAPI":"https:\u002F\u002Fwww.cbc.ca\u002F2019\u002Ffailover\u002Fcbc_pol.json"},"feedback":{"formName":null,"referringButtonId":""},"video":{"currentClip":{},"recommendations":{"items":[],"errors":[]},"acrossBaseCategoriesClips":{"items":[],"isLoaded":false},"liveClips":{"custom":{"items":[],"isLoaded":false},"onNow":{"items":[],"isLoaded":false},"upcoming":{"items":[],"isLoaded":false}},"category":{},"discoverCategories":[],"featuredCategories":[],"clipsByCategory":{},"trendingClips":{"items":[],"isLoaded":false},"childCategories":{"list":[],"more":[]},"localClips":{"items":[],"isLoaded":false}},"rightRail":{"path":"news\u002Fhealth","banner":null,"defaultHeadlineImage":"https:\u002F\u002Fi.cbc.ca\u002F1.470050.1431707740!\u002FfileImage\u002FhttpImage\u002Fdefault-headline-image-news.jpg","widgets":[]},"page":{"type":"","path":"","sections":[]}};</script>
            <script>window.__APP_VERSION__ = "aff9d424dbb24beb53967c4fabc9c048aa54b328";</script>
            <script src="/a/scripts/config.production.456a8e7d5bb308191a18.js"></script>
            <script src="//www.cbc.ca/g/stats/js/cbc-stats-top.js"></script>
            <script src="https://www.cbc.ca/i/caffeine/js/Caffeine.js"></script>
            <script>
                if (!window.CBC) { window.CBC = {}; }
                if (!CBC.APP) { CBC.APP = {}; }
                if (!CBC.APP.SC) { CBC.APP.SC = {}; }
                if (
                    typeof CBC !== "undefined" &&
                    typeof CBC.APP !== "undefined" &&
                    typeof CBC.APP.SC !== "undefined"
                ) {
                    CBC.APP.SC.preventDefault = true;
                }
            </script>
            <div id="app"><div class="appContainer detail newsTheme storyType healthSection viewportLarge loaded"><header class="globalHeader viewportLarge newsHeader"><a class="accessibilitySkipLink" href="#content">Skip to Main Content</a><div class="menuNavWrapper" role="dialog" aria-modal="false" aria-label="CBC main navigation" data-test="primaryNavbar"><button class="toggleMenu" tabindex="-1" aria-label="close menu" aria-hidden="true"></button><a class="logo" aria-label="CBC Home Page" href="/"><div class="icon"><svg class="logoIcon headerLogo" width="71px" height="18px" viewBox="0 0 71 18"><path d="M12.2646923,8.95707692 C12.2646923,10.719 10.8364615,12.1472308 9.07476923,12.1472308 C7.31307692,12.1472308 5.88484615,10.719 5.88484615,8.95707692 C5.88484615,7.19538462 7.31307692,5.76738462 9.07476923,5.76738462 C10.8364615,5.76738462 12.2646923,7.19538462 12.2646923,8.95707692" id="Fill-1" fill="#D8232A"></path><path d="M5.39307692,12.147 C3.63,12.147 2.20130769,10.719 2.20130769,8.95753846 C2.20130769,7.19561538 3.63,5.766 5.39284615,5.766 L5.39307692,12.147" id="Fill-2" fill="#D8232A"></path><path d="M12.7596923,15.6664615 L12.7603846,12.6394615 L15.7887692,12.6408462 C15.7887692,14.3141538 14.4323077,15.6664615 12.7596923,15.6664615" id="Fill-3" fill="#D8232A"></path><path d="M5.39284615,2.24469231 L5.39284615,5.27538462 L2.36053846,5.27584615 C2.36053846,3.60207692 3.71861538,2.24469231 5.39284615,2.24469231" id="Fill-4" fill="#D8232A"></path><path d="M5.39307692,15.6683077 L5.39307692,12.6394615 L2.36123077,12.6408462 C2.36123077,14.3139231 3.71792308,15.6683077 5.39307692,15.6683077" id="Fill-5" fill="#D8232A"></path><path d="M16.4455385,11.6986154 L16.4439231,6.21623077 C17.3778462,6.77238462 18.0034615,7.79169231 18.0034615,8.95753846 C18.0034615,10.1229231 17.3778462,11.1413077 16.4455385,11.6986154" id="Fill-6" fill="#D8232A"></path><path d="M6.33484615,1.58861538 L11.8174615,1.58953846 C11.2610769,0.655615385 10.2429231,0.0311538462 9.07684615,0.0311538462 C7.911,0.0311538462 6.89123077,0.655615385 6.33484615,1.58861538" id="Fill-7" fill="#D8232A"></path><path d="M11.7770769,16.3255385 L6.29353846,16.3248462 C6.85015385,17.2583077 7.869,17.8841538 9.03530769,17.8841538 C10.2011538,17.8841538 11.22,17.259 11.7770769,16.3255385" id="Fill-8" fill="#D8232A"></path><path d="M12.2658462,12.6408462 C12.2658462,14.4032308 10.8380769,15.831 9.07661538,15.831 C7.31423077,15.831 5.88484615,14.4032308 5.88484615,12.6408462 L12.2658462,12.6408462" id="Fill-9" fill="#D8232A"></path><path d="M12.7603846,12.147 C14.5220769,12.147 15.9514615,10.719 15.9514615,8.95753846 C15.9514615,7.19561538 14.5220769,5.766 12.7603846,5.766 L12.7603846,12.147" id="Fill-10" fill="#D8232A"></path><path d="M12.2658462,5.27907692 C12.2658462,3.51738462 10.8380769,2.08938462 9.07661538,2.08938462 C7.31423077,2.08938462 5.88484615,3.51738462 5.88484615,5.27907692 L12.2658462,5.27907692" id="Fill-11" fill="#D8232A"></path><path d="M1.70769231,11.6986154 L1.70907692,6.21623077 C0.774923077,6.77238462 0.150461538,7.79169231 0.150461538,8.95753846 C0.150461538,10.1229231 0.774923077,11.1413077 1.70769231,11.6986154" id="Fill-12" fill="#D8232A"></path><path d="M15.789,5.277 L12.7603846,5.27538462 L12.7596923,2.24746154 C14.4325385,2.24746154 15.789,3.60323077 15.789,5.277" id="Fill-13" fill="#D8232A"></path><path d="M29.9725385,17.8790769 C24.8926154,17.8790769 21.1197692,13.9583077 21.1197692,9.00184615 L21.1197692,8.95246154 C21.1197692,4.04538462 24.8187692,0.0258461538 30.1204615,0.0258461538 C33.3752308,0.0258461538 35.3233846,1.11092308 36.9263077,2.68915385 L34.5096923,5.47546154 C33.1781538,4.26738462 31.8219231,3.52753846 30.0957692,3.52753846 C27.186,3.52753846 25.0899231,5.94415385 25.0899231,8.90330769 L25.0899231,8.95246154 C25.0899231,11.9116154 27.1366154,14.3776154 30.0957692,14.3776154 C32.0683846,14.3776154 33.2769231,13.5883846 34.6331538,12.3553846 L37.0495385,14.7966923 C35.2742308,16.6954615 33.3013846,17.8790769 29.9725385,17.8790769" id="Fill-14" fill="#1A1919"></path><path d="M49.5923077,12.4465385 C49.5923077,11.2479231 48.6999231,10.5083077 46.6848462,10.5083077 L42.1451538,10.5083077 L42.1451538,14.436 L46.8124615,14.436 C48.5469231,14.436 49.5923077,13.8237692 49.5923077,12.4977692 L49.5923077,12.4465385 Z M48.5976923,5.30538462 C48.5976923,4.13215385 47.6796923,3.46915385 46.0218462,3.46915385 L42.1451538,3.46915385 L42.1451538,7.24361538 L45.7668462,7.24361538 C47.5010769,7.24361538 48.5976923,6.68261538 48.5976923,5.35638462 L48.5976923,5.30538462 Z M46.8124615,17.8790769 L38.3194615,17.8790769 L38.3194615,0.0258461538 L46.6084615,0.0258461538 C50.2555385,0.0258461538 52.5,1.83669231 52.5,4.64238462 L52.5,4.69338462 C52.5,6.70823077 51.4287692,7.83023077 50.1535385,8.54446154 C52.2193846,9.33507692 53.4946154,10.5336923 53.4946154,12.9313846 L53.4946154,12.9823846 C53.4946154,16.2468462 50.8421538,17.8790769 46.8124615,17.8790769 L46.8124615,17.8790769 Z" id="Fill-15" fill="#1A1919"></path><path d="M63.4393846,17.8790769 C58.3596923,17.8790769 54.5868462,13.9583077 54.5868462,9.00184615 L54.5868462,8.95246154 C54.5868462,4.04538462 58.2856154,0.0258461538 63.5875385,0.0258461538 C66.8423077,0.0258461538 68.7904615,1.11092308 70.3933846,2.68915385 L67.9767692,5.47546154 C66.645,4.26738462 65.2887692,3.52753846 63.5626154,3.52753846 C60.6530769,3.52753846 58.557,5.94415385 58.557,8.90330769 L58.557,8.95246154 C58.557,11.9116154 60.6036923,14.3776154 63.5626154,14.3776154 C65.5354615,14.3776154 66.7437692,13.5883846 68.1,12.3553846 L70.5166154,14.7966923 C68.7413077,16.6954615 66.7682308,17.8790769 63.4393846,17.8790769" id="Fill-16" fill="#1A1919"></path></svg></div></a><a class="menuButton" aria-controls="mainMenuNav" aria-label="Open Menu" aria-expanded="false" id="menuButton" role="button" href="//www.cbc.ca/sitemap">Menu<div class="icon"><svg class="chevronIcon" width="10px" height="10px" viewBox="0 0 10 10" focusable="false" aria-hidden="true"><g><path d="M10,0v3L5,7L0,3V0l5,4L10,0z"></path></g></svg></div></a><div class="sideMenu"><div class="headerSearchBar"><div class="searchBar compact"><form class="searchForm"><span class="search-autocomplete"><div role="combobox" aria-haspopup="listbox" aria-owns="react-autowhatever-gn-search-autocomplete" aria-expanded="false" class="react-autosuggest__container"><input type="search" value="" autoComplete="off" aria-autocomplete="list" aria-controls="react-autowhatever-gn-search-autocomplete" class="searchInput" name="query" id="gn-compact-search" placeholder="Search CBC.ca" aria-label="Search CBC.ca"/><div id="react-autowhatever-gn-search-autocomplete" role="listbox" class="react-autosuggest__suggestions-container" aria-label="Choose a suggestion"></div></div></span><button action="submit" class="searchButton">Search</button></form></div><button class="searchClose"><svg fill="#ffffff" width="20px" height="19px" viewBox="0 0 20 19" focusable="false" aria-label="close"><polygon points="20 0.01 17.6 0 10 7.6 2.4 0 0 0.01 8.79 8.81 0 17.6 2.44 17.57 10 10.02 17.56 17.57 20 17.6 11.21 8.81 20 0.01"></polygon></svg></button></div><a class="navLink search" aria-expanded="false" aria-label="Search" id="searchButton" role="button" href="/search"><div class="icon"><svg class="searchIcon headerSearch" width="15px" height="15px" viewBox="0 0 165 162" focusable="false"><path fill-rule="nonzero" d="M158.88247 135.38291L118.68966 95.4442c5.73759-9.30843 9.21631-20.15477 9.21631-31.88285C127.90597 29.56938 100.1562 2 65.953 2 31.74477 2 4 29.56938 4 63.56134c0 33.987 27.74477 61.56135 61.95299 61.56135 11.80269 0 22.71803-3.45674 32.08567-9.13801l40.19281 39.91868c2.82338 2.80553 7.50212 2.7855 10.3255 0l10.3255-10.26022c2.82337-2.80553 2.82337-7.4547 0-10.26023zm-92.92948-30.78067c-22.80887 0-41.302-18.37622-41.302-41.0409 0-22.66467 18.49313-41.0409 41.302-41.0409 22.80886 0 41.30199 18.37623 41.30199 41.0409 0 22.66468-18.49313 41.0409-41.302 41.0409z"></path></svg></div><span class="searchText">Search</span></a></div><nav class="menuNav sclt-menunav" aria-label="CBC Main" id="mainMenuNav" tabindex="-1"><div class="menuSidebar sclt-menuQuickLinks"><h5 class="menuSidebarHeading">Quick Links</h5><ul class="subNavList menuSidebarSubNav"><li class="navItem subNavListItem"><a class="navLink subNavLink nav-news" href="/news">News</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-sports" href="/sports">Sports</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-radio" href="/radio">Radio</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-music" href="/music">Music</a></li><li class="navItem subNavListItem"><a href="//www.cbc.ca/listen/" class="navLink subNavLink nav-listen-live">Listen Live</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-tv" href="/television">TV</a></li><li class="navItem subNavListItem"><a href="//watch.cbc.ca" class="navLink subNavLink nav-watch">Watch</a></li></ul></div><ul class="menuList mainMenu" aria-hidden="true" aria-label="Menu closed"></ul></nav><button class="menuClose sclt-menuRoundIconClose" aria-label="Close Menu"><div class="icon"><svg class="closeIcon" width="20px" height="19px" viewBox="0 0 20 19" focusable="false" aria-label="close"><polygon points="20 0.01 17.6 0 10 7.6 2.4 0 0 0.01 8.79 8.81 0 17.6 2.44 17.57 10 10.02 17.56 17.57 20 17.6 11.21 8.81 20 0.01"></polygon></svg></div></button></div><div class="globalEventNav"><nav class="globalEventNav-nav sclt-globalEventNav" aria-label="COVID-19"><ul class="responsiveNav subNavList" id=""><li class="gemWrapper subNavListItem"><a class="gemWrapper-link" href="/news/covid-19">COVID-19</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink firstItem nav-local-updates" href="/news/local">Local updates</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-live-video" href="/player/news/live">Live video</a></li><li class="navItem subNavListItem"><a href="https://newsinteractives.cbc.ca/coronavirustracker/" class="navLink subNavLink nav-covid-19-tracker">COVID-19 tracker</a></li><li class="navItem subNavListItem"><a href="https://subscriptions.cbc.ca/listmanagement/forms/coronavirusbrief?cmp=feed-gen_coronavirusbrief_newsletter-subscribe" class="navLink subNavLink nav-subscribe-to-newsletter">Subscribe to newsletter</a></li></ul></nav></div><nav class="sclt-landingnav landingNav" aria-label="CBC news"><div class="landingWrapper"><ul class="responsiveNav subNavList" id=""><li class="gemWrapper subNavListItem"><div class="gemSectionLink" id="section-link-title"><div class="icon"><svg class="logoIcon detailGem" width="34px" height="34px" viewBox="0 0 100 100" focusable="false"><path d="M 41.647569,55.601135 C 49.353153,55.601135 55.600748,49.353577 55.600748,41.65033 C 55.600748,33.942505 49.353153,27.695862 41.647569,27.695862 C 33.938783,27.695862 27.688441,33.942505 27.688441,41.65033 C 27.688441,49.353577 33.938783,55.601135 41.647569,55.601135 z "></path><path d=""></path><path d="M 25.53465,55.601135 C 17.823576,55.601135 11.57415,49.353577 11.57415,41.65033 C 11.57415,33.942505 17.823576,27.690369 25.534193,27.690369 L 25.53465,55.601135 z "></path><path d="M 57.757743,70.996643 L 57.761402,57.755371 L 71.009159,57.76178 C 71.009159,65.080505 65.074675,70.996643 57.757743,70.996643 z "></path><path d="M 25.534193,25.542541 L 12.269954,25.544372 C 12.269954,18.223815 18.210847,12.286622 25.534193,12.286622"></path><path d="M 25.53465,71.003967 L 25.53465,57.755371 L 12.273617,57.76178 C 12.273617,65.080505 18.207642,71.003967 25.53465,71.003967 z "></path><path d="M 73.880269,53.640075 L 73.872946,29.658752 C 77.958054,32.092225 80.695496,36.549927 80.695496,41.65033 C 80.695496,46.74707 77.958054,51.202026 73.880269,53.640075 z "></path><path d="M 29.65409,9.416443 L 53.636012,9.4201053 C 51.202525,5.3350221 46.749374,2.6030886 41.6494,2.6030886 C 36.548509,2.6030886 32.088491,5.3350221 29.65409,9.416443 z "></path><path d="M 53.460228,73.878723 L 29.474187,73.875976 C 31.909047,77.958312 36.365402,80.695739 41.466294,80.695739 C 46.566268,80.695739 51.023081,77.961975 53.460228,73.878723 z "></path><path d="M 55.597084,57.76178 C 55.597084,65.47052 49.353153,71.716247 41.647569,71.716247 C 33.938783,71.716247 27.68661,65.47052 27.68661,57.761779 L 55.597084,57.76178 z "></path><path d="M 57.761402,55.601135 C 65.466527,55.601135 71.719616,49.353577 71.719616,41.65033 C 71.719616,33.942506 65.466527,27.690369 57.761402,27.690369 L 57.761402,55.601135 z "></path><path d="M 55.597084,25.559022 C 55.597084,17.853942 49.353153,11.606385 41.647569,11.606385 C 33.938783,11.606385 27.68661,17.853942 27.68661,25.559022 L 55.597084,25.559022 z "></path><path d="M 9.4144081,53.640075 L 9.4203588,29.658752 C 5.3338786,32.092225 2.6028445,36.549927 2.6028445,41.65033 C 2.6028445,46.74707 5.3338786,51.202026 9.4144081,53.640075 z "></path><path d="M 57.761402,25.542541 L 57.757743,12.298523 C 65.074675,12.298523 71.009159,18.229309 71.009159,25.551697"></path></svg></div><a class="navLink subNavLink" href="/news"><div class="icon"><svg width="82px" height="20px" viewBox="0 0 82 20" version="1.1"><g id="Page-1" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g id="Artboard" transform="translate(-30.000000, -376.000000)" fill="#FFFFFE"><g id="Group-16" transform="translate(30.000000, 376.000000)"><g id="Group-17" transform="translate(-0.000000, 0.000000)"><polyline id="Fill-17" points="14.5941026 0.00794871795 16.7764103 0.00794871795 16.7764103 19.8448718 14.9910256 19.8448718 2.18230769 3.57871795 2.18230769 19.8448718 -2.82440737e-13 19.8448718 -2.82440737e-13 0.00794871795 2.09692308 0.00794871795 14.5941026 15.9058974 14.5941026 0.00794871795"></polyline><polyline id="Fill-18" points="35.3851282 2.04846154 23.2846154 2.04846154 23.2846154 8.82128205 34.11 8.82128205 34.11 10.8615385 23.2846154 10.8615385 23.2846154 17.804359 35.5269231 17.804359 35.5269231 19.8448718 21.0461538 19.8448718 21.0461538 0.00794871795 35.3851282 0.00794871795 35.3851282 2.04846154"></polyline><polyline id="Fill-19" points="51.1828205 0.0120512821 53.0064103 0.0120512821 58.3935897 16.425641 64.0287179 0.0125641026 66.3571795 0.0125641026 59.3192308 19.8489744 57.4394872 19.8489744 52.0523077 3.91179487 46.6371795 19.8489744 44.7851282 19.8489744 37.7512821 0.0125641026 40.164359 0.0125641026 45.795641 16.425641 51.1828205 0.0120512821"></polyline><path d="M74.9405128,8.87179487 C79.2384615,9.80820513 81.2225641,11.3789744 81.2225641,14.354359 C81.2225641,17.6882051 78.4669231,19.8369231 74.6376923,19.8369231 C71.5789744,19.8369231 69.0720513,18.8179487 66.7574359,16.7512821 L68.1076923,15.1533333 C70.1189744,16.9717949 72.0474359,17.8807692 74.7202564,17.8807692 C77.31,17.8807692 79.0182051,16.5310256 79.0182051,14.5748718 C79.0182051,12.7564103 78.0538462,11.7366667 74.0038462,10.8828205 C69.5676923,9.91846154 67.5292308,8.48589744 67.5292308,5.29 C67.5292308,2.20410256 70.2015385,1.77635684e-15 73.8661538,1.77635684e-15 C76.6761538,1.77635684e-15 78.6876923,0.798974359 80.6435897,2.36974359 L79.3764103,4.05 C77.5853846,2.58974359 75.7948718,1.95615385 73.8107692,1.95615385 C71.3038462,1.95615385 69.705641,3.33384615 69.705641,5.09717949 C69.705641,6.94307692 70.6974359,7.96230769 74.9405128,8.87179487" id="Fill-20"></path></g></g></g></g></svg></div></a></div></li><li class="navItem subNavListItem"><a class="navLink subNavLink firstItem nav-top-stories" href="/news">Top Stories</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-local" href="/news/local">Local</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-the-national" href="/news/thenational">The National</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-opinion" href="/news/opinion">Opinion</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-world" href="/news/world">World</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-canada" href="/news/canada">Canada</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-politics" href="/news/politics">Politics</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-indigenous" href="/news/indigenous">Indigenous</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-business" href="/news/business">Business</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-health" href="/news/health">Health</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-entertainment" href="/news/entertainment">Entertainment</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-tech-science" href="/news/technology">Tech &amp; Science</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-cbc-news-investigates" href="/news/investigates">CBC News Investigates</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-go-public" href="/news/gopublic">Go Public</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-shows" href="/news/shows">Shows</a></li><li class="navItem subNavListItem"><a class="navLink subNavLink nav-about-cbc-news" href="/news/about-cbc-news-1.1294364">About CBC News</a></li></ul></div></nav><div class="detailNav"><div class="detailNavCentered sclt-detailnav"><div class="gemSectionLink" id="section-link-title"><div class="icon"><svg class="logoIcon detailGem" width="34px" height="34px" viewBox="0 0 100 100" focusable="false"><path d="M 41.647569,55.601135 C 49.353153,55.601135 55.600748,49.353577 55.600748,41.65033 C 55.600748,33.942505 49.353153,27.695862 41.647569,27.695862 C 33.938783,27.695862 27.688441,33.942505 27.688441,41.65033 C 27.688441,49.353577 33.938783,55.601135 41.647569,55.601135 z "></path><path d=""></path><path d="M 25.53465,55.601135 C 17.823576,55.601135 11.57415,49.353577 11.57415,41.65033 C 11.57415,33.942505 17.823576,27.690369 25.534193,27.690369 L 25.53465,55.601135 z "></path><path d="M 57.757743,70.996643 L 57.761402,57.755371 L 71.009159,57.76178 C 71.009159,65.080505 65.074675,70.996643 57.757743,70.996643 z "></path><path d="M 25.534193,25.542541 L 12.269954,25.544372 C 12.269954,18.223815 18.210847,12.286622 25.534193,12.286622"></path><path d="M 25.53465,71.003967 L 25.53465,57.755371 L 12.273617,57.76178 C 12.273617,65.080505 18.207642,71.003967 25.53465,71.003967 z "></path><path d="M 73.880269,53.640075 L 73.872946,29.658752 C 77.958054,32.092225 80.695496,36.549927 80.695496,41.65033 C 80.695496,46.74707 77.958054,51.202026 73.880269,53.640075 z "></path><path d="M 29.65409,9.416443 L 53.636012,9.4201053 C 51.202525,5.3350221 46.749374,2.6030886 41.6494,2.6030886 C 36.548509,2.6030886 32.088491,5.3350221 29.65409,9.416443 z "></path><path d="M 53.460228,73.878723 L 29.474187,73.875976 C 31.909047,77.958312 36.365402,80.695739 41.466294,80.695739 C 46.566268,80.695739 51.023081,77.961975 53.460228,73.878723 z "></path><path d="M 55.597084,57.76178 C 55.597084,65.47052 49.353153,71.716247 41.647569,71.716247 C 33.938783,71.716247 27.68661,65.47052 27.68661,57.761779 L 55.597084,57.76178 z "></path><path d="M 57.761402,55.601135 C 65.466527,55.601135 71.719616,49.353577 71.719616,41.65033 C 71.719616,33.942506 65.466527,27.690369 57.761402,27.690369 L 57.761402,55.601135 z "></path><path d="M 55.597084,25.559022 C 55.597084,17.853942 49.353153,11.606385 41.647569,11.606385 C 33.938783,11.606385 27.68661,17.853942 27.68661,25.559022 L 55.597084,25.559022 z "></path><path d="M 9.4144081,53.640075 L 9.4203588,29.658752 C 5.3338786,32.092225 2.6028445,36.549927 2.6028445,41.65033 C 2.6028445,46.74707 5.3338786,51.202026 9.4144081,53.640075 z "></path><path d="M 57.761402,25.542541 L 57.757743,12.298523 C 65.074675,12.298523 71.009159,18.229309 71.009159,25.551697"></path></svg></div><a class="navLink subNavLink" href="/news"><div class="icon"><svg width="82px" height="20px" viewBox="0 0 82 20" version="1.1"><g id="Page-1" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g id="Artboard" transform="translate(-30.000000, -376.000000)" fill="#FFFFFE"><g id="Group-16" transform="translate(30.000000, 376.000000)"><g id="Group-17" transform="translate(-0.000000, 0.000000)"><polyline id="Fill-17" points="14.5941026 0.00794871795 16.7764103 0.00794871795 16.7764103 19.8448718 14.9910256 19.8448718 2.18230769 3.57871795 2.18230769 19.8448718 -2.82440737e-13 19.8448718 -2.82440737e-13 0.00794871795 2.09692308 0.00794871795 14.5941026 15.9058974 14.5941026 0.00794871795"></polyline><polyline id="Fill-18" points="35.3851282 2.04846154 23.2846154 2.04846154 23.2846154 8.82128205 34.11 8.82128205 34.11 10.8615385 23.2846154 10.8615385 23.2846154 17.804359 35.5269231 17.804359 35.5269231 19.8448718 21.0461538 19.8448718 21.0461538 0.00794871795 35.3851282 0.00794871795 35.3851282 2.04846154"></polyline><polyline id="Fill-19" points="51.1828205 0.0120512821 53.0064103 0.0120512821 58.3935897 16.425641 64.0287179 0.0125641026 66.3571795 0.0125641026 59.3192308 19.8489744 57.4394872 19.8489744 52.0523077 3.91179487 46.6371795 19.8489744 44.7851282 19.8489744 37.7512821 0.0125641026 40.164359 0.0125641026 45.795641 16.425641 51.1828205 0.0120512821"></polyline><path d="M74.9405128,8.87179487 C79.2384615,9.80820513 81.2225641,11.3789744 81.2225641,14.354359 C81.2225641,17.6882051 78.4669231,19.8369231 74.6376923,19.8369231 C71.5789744,19.8369231 69.0720513,18.8179487 66.7574359,16.7512821 L68.1076923,15.1533333 C70.1189744,16.9717949 72.0474359,17.8807692 74.7202564,17.8807692 C77.31,17.8807692 79.0182051,16.5310256 79.0182051,14.5748718 C79.0182051,12.7564103 78.0538462,11.7366667 74.0038462,10.8828205 C69.5676923,9.91846154 67.5292308,8.48589744 67.5292308,5.29 C67.5292308,2.20410256 70.2015385,1.77635684e-15 73.8661538,1.77635684e-15 C76.6761538,1.77635684e-15 78.6876923,0.798974359 80.6435897,2.36974359 L79.3764103,4.05 C77.5853846,2.58974359 75.7948718,1.95615385 73.8107692,1.95615385 C71.3038462,1.95615385 69.705641,3.33384615 69.705641,5.09717949 C69.705641,6.94307692 70.6974359,7.96230769 74.9405128,8.87179487" id="Fill-20"></path></g></g></g></g></svg></div></a></div><span class="detailNavHeadline">Antibody drugs are no cure but seem promising for COVID-19</span><div class="share"><div class="viafoura"><h2 class="a11y">Social Sharing</h2><div class="vf-widget vf-share-bar-horizontal" data-widget="sharebar" data-button-view="true" data-url="news/health/covid-19-antibody-treatments-1.5755755" data-show-labels="true" data-show-counters="false" data-show-total="false"></div></div></div></div></div></header><div class="ad-risingstar-container"></div><main class="feed-content content" id="content"><div class="detail detailBody pageComponent"><div></div><div class="detailBodyContainer"><div class="detailMainCol sclt-storycontent"><span class="detail-link-label sclt-storySectionLink"><a class="" href="/news/health">Health</a></span><h1 class="detailHeadline">Antibody drugs are no cure but seem promising for COVID-19</h1><div class="detailSummary">Experimental antibody drugs being tested for treating and preventing coronavirus infections.</div><div class="share"><div class="viafoura"><h2 class="a11y">Social Sharing</h2><div class="vf-widget vf-share-bar-horizontal" data-widget="sharebar" data-button-view="false" data-url="https://www.cbc.ca/news/health/covid-19-antibody-treatments-1.5755755" data-show-labels="true" data-show-counters="false" data-show-total="false"></div></div></div><h2 class="deck">Experimental treatments aim to help the immune system clear the virus</h2><div class="byline"><div class="bylineDetails">The Associated Press<span class="bullet"> · </span><time class="timeStamp" dateTime="2020-10-08T20:27:59.511Z">Posted: Oct 08, 2020 4:27 PM ET | Last Updated: October 8</time></div></div><div class="storyWrapper"><figure class="imageMedia leadmedia-story full"><div class="placeholder"><div class="placeholderImage" style="padding-bottom:56.25%"></div><img loading="lazy" alt="" srcSet="" sizes="" src="https://i.cbc.ca/1.5755765.1602185123!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_780/virus-outbreak-antibody-drugs.jpg"/></div><figcaption class="image-caption">In this undated image from video provided by Regeneron Pharmaceuticals on Oct. 2, vials are inspected at the company&#x27;s facilities in New York state, for efforts on an experimental coronavirus antibody drug. <!-- --> <!-- -->(Regeneron/Associated Press)</figcaption></figure><div class="story"><span><p>They&#x27;re not cures and it&#x27;s not likely that everyone will be able to get them as U.S. President Donald Trump has suggested. But experimental antibody drugs like the one Trump was given are among the most promising therapies being tested for treating and preventing coronavirus infections.</p>  <p>Eli Lilly and Regeneron Pharmaceuticals Inc. are asking the U.S. government to allow emergency use of their antibody drugs, which aim to help the immune system clear the virus. The medicines are still in testing; their safety and effectiveness are not yet known.</p><section id="inread-wrapper-id-10402277"></section>  <p><em><strong>WATCH | Trump&#x27;s COVID-19 treatments:</strong></em></p>  <div><span><span class="mediaEmbed"><div class="player-placeholder-ui-container "><div class="player-placeholder-video-ui" role="button" tabindex="0" title="Trump given COVID-19 treatments for varying degrees of illness"><div class="placeholder  "><div class="thumbnail"><img src="https://thumbnails.cbc.ca/maven_legacy/thumbnails/174/963/covid19-trump-treatment-birak-051020.jpg" alt=""/></div><div class="controls"><div class="play-button-container" aria-label="Play"><svg class="play-btn" viewBox="0 0 80 80" focusable="false"><path d="m30.22 20.25c-0.2231 4.435-0.09351 8.89-0.1419 13.33 0.0088 8.737-0.0362 17.48 0.07256 26.21 10.54-6.515 21.05-13.07 31.52-19.69-2.395-1.814-5.047-3.302-7.568-4.948-7.952-4.981-15.92-9.972-23.89-14.91z"></path></svg></div><div class="media-metadata "><h3 class="media-title">Trump given COVID-19 treatments for varying degrees of illness</h3><div class="media-labels"><span class="formattedDate media-airdate" aria-label="From 9 days ago">9 days ago</span><div class="videoInfoLabel"><div class="videoDuration"><span aria-label="duration 2:00">2:00</span><svg class="captions" viewBox="0 0 14 9.5" width="13px" height="13px" aria-label="Close captions available"><path d="m12.5,0c0.6875,0 1.25,0.5625 1.25,1.25l0,7.5c0,0.6875 -0.5625,1.25 -1.25,1.25l-8.75,0c-0.69375,0 -1.25,-0.5625 -1.25,-1.25l0,-7.5c0,-0.6875 0.55625,-1.25 1.25,-1.25l8.75,0zm-5,4.375l0,-0.625c0,-0.34375 -0.28125,-0.625 -0.625,-0.625l-1.875,0c-0.34375,0 -0.625,0.28125 -0.625,0.625l0,2.5c0,0.34375 0.28125,0.625 0.625,0.625l1.875,0c0.34375,0 0.625,-0.28125 0.625,-0.625l0,-0.625l-0.9375,0l0,0.3125l-1.25,0l0,-1.875l1.25,0l0,0.3125l0.9375,0zm4.375,0l0,-0.625c0,-0.34375 -0.28125,-0.625 -0.625,-0.625l-1.875,0c-0.34375,0 -0.625,0.28125 -0.625,0.625l0,2.5c0,0.34375 0.28125,0.625 0.625,0.625l1.875,0c0.34375,0 0.625,-0.28125 0.625,-0.625l0,-0.625l-0.9375,0l0,0.3125l-1.25,0l0,-1.875l1.25,0l0,0.3125l0.9375,0z"></path></svg></div></div></div></div></div></div></div></div><span class="media-caption">U.S. President Donald Trump has received 3 different treatments for COVID-19, which are separately designed to treat patients with mild, moderate and severe symptoms.<!-- --> <!-- -->2:00</span></span></span></div>  <p>Trump is among fewer than 10 people who were able to access the Regeneron one under &quot;compassionate use&quot; rules, without enrolling in a study.</p>  <h2>Q: How do they work?</h2>  <p>A: Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production. But it can take several weeks after a vaccine or natural infection for the most effective antibodies to form. The experimental drugs are concentrated versions of specific antibodies that worked best against the coronavirus in lab and animal tests. In theory, they start helping right away. The one-time treatment is given through an IV — it&#x27;s not like a pill that people can take at home.</p>  <h2>Q: How do the drugs differ?</h2>  <p>A: Regeneron is using two antibodies to enhance chances its therapy will work even if the virus evades one. The company made a successful Ebola combo antibody treatment this way. Lilly is testing two different antibodies — one with the Canadian company <a href="http://cbc.ca/1.5507232">AbCellera</a> and another with a Chinese company, Junshi Biosciences — individually and in combination.</p>  <p>Others testing similar drugs are GlaxoSmithKline and Vir Biotechnology Inc., which says it has engineered antibodies to last longer than they usually do. Amgen, Adaptive Biotechnologies and the Singapore biotech company Tychan Pte Ltd. also have studies underway.</p>  <h2>Q: When might they be available?</h2>  <p>A: Eli Lilly and Regeneron have asked the U.S. Food and Drug Administration for emergency authorization. During public health emergencies the FDA can speed drugs to market based on a lower standard of evidence than is normally required.</p>  <p>Drugmakers need only show that the expected benefits of their therapies outweigh the risks for treating COVID-19. There is no deadline for the FDA to rule on the drugs, but it typically makes decisions on such emergency applications within days or weeks.</p>  <h2>Q: Who would get them?</h2>  <p>A: Researchers are still trying to determine the best candidates for antibody treatment. Some studies involve newly infected people to see if early treatment can lower the risk of becoming sick. Other studies in hospitalized patients aim to prevent serious illness, complications or death. Researchers also are testing these drugs to try to prevent infection in people at high risk of it, such as health workers, housemates of people with COVID-19, and nursing home workers and residents.</p>  <h2>Q: Will there be enough for everyone?</h2>  <p>A: It depends on how potent the drugs prove to be, something still being studied. If a high dose is needed to be effective, it will mean that fewer people can be treated with limited supplies. Regeneron says it has enough doses for approximately 50,000 patients and expects 300,000 available within the next few months.</p>  <p>Under a $450 million US contract, the U.S. government has agreed to buy initial supplies of Regeneron&#x27;s drug and distribute them at no cost to U.S. patients. Lilly says it expects to have 1 million doses this year of the single antibody that it submitted to FDA. However, the company&#x27;s research has focused on a combination of two antibodies to treat COVID-19 patients. Lilly said it expects to have just 50,000 doses of that combo this year.</p>  <h2>Q: What&#x27;s the evidence that they work?</h2>  <p>A: Lilly and Regeneron have revealed only partial results in news releases; they haven&#x27;t been published or vetted by independent scientists. Lilly said Wednesday that its two-antibody combo reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19. The results are an interim look at a mid-stage study in which 112 people received the antibodies and 156 got a placebo.</p>  <p>The amount of virus was significantly lower 11 days later in those given the drug — the main goal of the study. About 5.8 per cent of patients given placebo required hospitalization or an emergency room visit versus 0.9 per cent of those given the antibodies. Previously, Regeneron said its drug reduced the amount of virus and symptoms in non-hospitalized patients. The partial results came from the first 275 patients enrolled in ongoing studies.</p></span></div></div><div class="contentFeedback"><div class="bottomSeparator"><a href="https://cbc.radio-canada.ca/en/vision/governance/journalistic-standards-and-practices" class="journalistLink">CBC&#x27;s Journalistic Standards and Practices</a><span class="separator">|</span><a href="/news/about-cbc-news-1.1294364" class="trustProjectLink">About CBC <!-- -->News</a></div><button class="reportIssue feedbackButton" id="">Report Typo or Error</button></div></div><div class="detailSideRail"><div class="stickyContainer stickyRailAd"></div><div class="stickyContainer"><div class="detailDiscovery"><div class="lazy-load"></div></div></div></div><div class="lazy-load"></div><div class="detailDiscovery"><div class="lazy-load"></div><div class="lazy-load"></div></div><script type="application/ld+json">{"@context":"http://schema.org/","@type":"WebPage","speakable":{"@type":"SpeakableSpecification","cssSelector":[".detailHeadline",".detailSummary"]}}</script></div></div></main><footer class="globalFooter sclt-footer" role="contentinfo" aria-label="CBC Footer"><div class="footerBody extendedFooter"><h2 class="a11y">Footer Links</h2><div class="footerColumn account" data-test-id="footer-column-service"><h3 class="footerHeading">My Account</h3><ul class="footerList"><li class="footerItem"><a href="https://www.cbc.ca/account/" class="footerLink">Profile</a></li><li class="footerItem"><a href="https://gem.cbc.ca/benefits/" class="footerLink">CBC Gem</a></li><li class="footerItem"><a href="https://subscriptions.cbc.ca/listmanagement/" class="footerLink">Newsletters</a></li></ul></div><div class="footerColumn connect"><h3 class="footerHeading">Connect with CBC</h3><ul class="footerList"><li class="footerItem"><a href="https://www.facebook.com/cbc/" class="footerLink">Facebook</a></li><li class="footerItem"><a href="https://twitter.com/cbc/" class="footerLink">Twitter</a></li><li class="footerItem"><a href="https://www.youtube.com/user/CBCtv" class="footerLink">YouTube</a></li><li class="footerItem"><a href="https://www.instagram.com/cbc/?hl=en" class="footerLink">Instagram</a></li><li class="footerItem"><a href="https://cbchelp.cbc.ca/hc/en-ca/categories/115000249853-Help-with-CBC-Apps" class="footerLink">Mobile</a></li><li class="footerItem"><a href="https://www.cbc.ca/rss/" class="footerLink">RSS</a></li><li class="footerItem"><a class="footerLink" href="/radio/podcasts">Podcasts</a></li></ul></div><div class="footerColumn contact"><h3 class="footerHeading">Contact CBC</h3><ul class="footerList"><li class="footerItem"><a href="https://cbchelp.cbc.ca/hc/en-ca/requests/new" class="footerLink">Submit Feedback</a></li><li class="footerItem"><a href="https://cbchelp.cbc.ca/hc/en-ca" class="footerLink">Help Centre</a></li></ul><p>Audience Relations, CBC <br/>P.O. Box 500 Station A <br/>Toronto, ON <br/> Canada, M5W 1E6<!-- --> </p><p>Toll-free (Canada only): <br/> 1-866-306-4636</p><p>TTY/Teletype writer: <br/> 1-866-220-6045</p></div><div class="footerColumn about" data-test-id="footer-column-service"><h3 class="footerHeading">About CBC</h3><ul class="footerList"><li class="footerItem"><a href="https://cbc.radio-canada.ca/en" class="footerLink">Corporate Info</a></li><li class="footerItem"><a class="footerLink" href="/sitemap">Sitemap</a></li><li class="footerItem"><a href="https://cbchelp.cbc.ca/hc/en-ca/sections/203864688-Using-or-licensing-CBC-content" class="footerLink">Reuse &amp; Permission</a></li><li class="footerItem"><a href="https://cbc.radio-canada.ca/en/vision/governance/terms-of-use-digital-services" class="footerLink">Terms of Use</a></li><li class="footerItem"><a href="https://www.cbc.ca/mycbc/cbc-and-your-data-1.5514726" class="footerLink">Privacy</a></li><li class="footerItem"><a href="https://cbc.radio-canada.ca/en/working-with-us/jobs/" class="footerLink">Jobs</a></li><li class="footerItem"><a href="https://cbc.radio-canada.ca/en/vision/unions-associations" class="footerLink">Our Unions</a></li><li class="footerItem"><a href="https://www.cbc.ca/ip" class="footerLink">Independent Producers</a></li><li class="footerItem"><a href="https://cbc.radio-canada.ca/en/impact-and-accountability/regulatory/political-ads-registry" class="footerLink">Political Ads Registry</a></li><li class="footerItem"><a href="https://youradchoices.ca" class="footerLink" rel="nofollow">AdChoices</a></li></ul></div><div class="footerColumn connect" data-test-id="footer-column-service"><h3 class="footerHeading">Services</h3><ul class="footerList"><li class="footerItem"><a href="https://cbc.radio-canada.ca/en/ombudsman/" class="footerLink">Ombudsman</a></li><li class="footerItem"><a href="https://www.cbc.ca/news/public-appearances-1.4969965" class="footerLink">Public Appearances</a></li><li class="footerItem"><a href="https://cbc.radio-canada.ca/en/services/commercial-services/" class="footerLink">Commercial Services</a></li><li class="footerItem"><a href="http://www.cbcshop.ca/" class="footerLink">CBC Shop</a></li><li class="footerItem"><a href="https://cbc.radio-canada.ca/en/working-with-us/partners-and-suppliers/" class="footerLink">Doing Business with Us</a></li><li class="footerItem"><a href="https://www.cbc.ca/productionfacilities/" class="footerLink">Renting Facilities</a></li></ul></div><div class="footerColumn accessibility"><h3 class="footerHeading">Accessibility</h3><div class="footerColumnBody"><p>It is a priority for CBC to create a website that is accessible to all Canadians including people with visual, hearing, motor and cognitive challenges.</p><p>Closed Captioning and Described Video is available for many CBC shows offered on<!-- --> <a href="https://watch.cbc.ca/" class="footerLink cbcWatch">CBC Gem</a>.</p><ul class="footerList"><li class="footerItem"><a href="https://www.cbc.ca/accessibility/" class="footerLink">About CBC Accessibility</a></li><li class="footerItem"><a href="https://www.cbc.ca/accessibility/feedback/" class="footerLink">Accessibility Feedback</a></li></ul></div></div></div><div class="basicFooter"><ul class="footerBody footerList"><li class="footerColumn extendedLogo"><a href="http://www.cbc.radio-canada.ca/" class="extendedLogoLink" aria-label="CBC/Radio-Canada"><figure class="imageMedia image full"><div class="placeholder"><div class="placeholderImage" style="padding-bottom:56.25%"></div><img loading="lazy" alt="" srcSet="" sizes="" src="/a/static/media/logo_cbc-radio-canada.svg"/></div></figure></a></li><li class="footerColumn copyright"><span role="img" aria-label="copyright">©</span>2020<!-- --> CBC/Radio-Canada. All rights reserved.<!-- --> </li><li class="footerColumn radioCanada"><a href="http://ici.radio-canada.ca/" class="radioCanada" hrefLang="fr-CA" lang="fr-CA"><span>Visitez Radio-Canada.ca</span></a></li></ul></div></footer><div class="persistent-player-persist-container pp-hidden video " id="persistent-player" tabindex="-1" aria-labelledby="persistent-player-media-metadata-video persistent-player-media-metadata-audio"><div class="persistent-player-inner-container hide-dock-btn"><div class="persistent-player native-ui  "><div class="pp-caffeine-container "></div></div><div class="persistent-player-video-ui"><div><button class="close-persistent-player-button" aria-label="Close persistent player"><div class="icon"><svg class="closeIcon" width="20px" height="19px" viewBox="0 0 20 19" focusable="false" aria-label="close"><polygon points="20 0.01 17.6 0 10 7.6 2.4 0 0 0.01 8.79 8.81 0 17.6 2.44 17.57 10 10.02 17.56 17.57 20 17.6 11.21 8.81 20 0.01"></polygon></svg></div></button></div><div id="persistent-player-media-metadata-video"><h3 class="media-title"></h3><div class="showname-and-timestamp"><p class="media-showname"></p><span class="formattedDate media-timestamp" aria-label="From now">now</span></div></div></div></div></div></div></div>
            <script src="//www.cbc.ca/g/stats/js/cbc-stats-bottom.js"></script>

            <script async src="//cdn.viafoura.net/vf-v2.js"></script><script>window.vfConfig = {"loginradius_api_key":"3f4beddd-2061-49b0-ae80-6f1f2ed65b37","loginradius_app_name":"cbc-login"}</script>
            <div
                id="a11yNotification"
                class="a11y"
                role="region"
                aria-live="polite"
            ></div>
            <script id="__LOADABLE_REQUIRED_CHUNKS__" type="application/json">[3,4,0,1,10]</script><script id="__LOADABLE_REQUIRED_CHUNKS___ext" type="application/json">{"namedChunks":["Detail"]}</script>
<script async data-chunk="app" src="/a/scripts/runtime.85a465446ba6cd41e3f9.js"></script>
<script async data-chunk="app" src="/a/scripts/react.fe75a712eb78fd26b2cb.js"></script>
<script async data-chunk="app" src="/a/scripts/vendor.be7d21571f35ecbfe132.js"></script>
<script async data-chunk="app" src="/a/scripts/app.638f1338f55e344a00bd.js"></script>
<script async data-chunk="Detail" src="/a/scripts/vendors~Detail~Detail.NoDate~DetailNoAds~Index~Landing~Landing.NoDate~Landing.NoLoadMore~LandingFeat~970bb718.13aed3c6f60a4a95b273.js"></script>
<script async data-chunk="Detail" src="/a/scripts/vendors~Detail~Detail.NoDate~DetailNoAds~Preview.916679f692a7f8532fed.js"></script>
<script async data-chunk="Detail" src="/a/scripts/ErrorPage.38bd081a56974bdfaa7a.js"></script>
<script async data-chunk="Detail" src="/a/scripts/BlankPage~Detail~Detail.NoDate~DetailNoAds~FinancePage~Index~Landing~Landing.NoDate~Landing.NoLoadMo~524c369c.752336a0b79086df605d.js"></script>
<script async data-chunk="Detail" src="/a/scripts/Detail.32dda8c9fbfebbee57a9.js"></script>
        </body>
    </html>